Palomar, Syneron settle patent spat for $31M plus royalties | Legal News

Palomar
Syneron

Syneron Medical Ltd. (NSDQ:ELOS) agreed to pony up $31 million plus royalties for the rights to a pair of Palomar Medical Technologies (NSDQ:PMTI) patents for laser- and light-based hair removal technologies, ending a long-running legal battle.

Syneron inherited the imbroglio when it acquired Palomar’s Bay State rival, Candela Corp., for $65 million in January 2010. The case dates back to a pair of patents Burlington, Mass.-based Palomar licensed from Mass. General Hospital back in 1995 for light-based hair removal.

Palomar had accused Candela (and then Syneron) of willfully copying its technology. Today Syneron and Palomar announced a deal that will see Yokneam, Israel-based Syneron dish out $31 million in up-front cash for the rights to the two patents in the case. Syneron will also pay out royalties on sales of "consumer home-use lamp-based hair removal products," according to a press release.

Sign up to get our free newsletters delivered right to your inbox

The royalties are structured to deliver 5.0 percent "up to up to an undisclosed amount of cumulative sales," then 6.5 percent up to another secret milestone and 7.5 percent after that, according to the release. The deal also includes provisions for Palomar to license Syneron and Candela patents royalty-free. Forty percent of of all payments from the deal will go, in turn, to the General Hospital Corp., which owns Mass. General.

"Palomar pioneered the cosmetic light-based industry with the first high-powered laser hair removal system in 1997," Palomar president & CEO Joseph Caruso, said in prepared remarks. "Our intellectual property strategy has proved to be a valuable asset for our shareholders and we will continue to focus on expanding our intellectual property in the future."

“We are pleased to reach a mutually beneficial settlement that effectively ends the patent disputes between Syneron and Palomar," added Syneron CEO Louis Scafuri. "Syneron has a very strong balance sheet and we believe this fully paid-up license is a strategically beneficial utilization of our cash. It eliminates our exposure to continued legal liability in the matter, does not require any additional payments for professional hair removal systems, and supports our ongoing efforts to improve the company’s gross and operating margins.”

Read more medical device legal news from MassDevice.com

  • Merge Healthcare slips insurance lawsuit over Amicas deal
    Merge Healthcare Inc. (NSDQ:MRGE) is long party to a lawsuit filed by an insurance company looking to avoid paying out more than $2.5 million to cover a lawsuit filed against Merge subsidiary Amicas before the merger.

    Amicas shareholders had filed a separate lawsuit looking to block a buyout by private equity firm Thoma Bravo LLC last year. When that deal fell apart and Merge managed to consummate its deal, the shareholders suit was dismissed – but not before the judge ordered Merge to pay nearly $3.2 million in legal fees and expenses.
    Enter Carolina Casualty Insurance Co., Merge’s insurer, which filed a lawsuit against Merge and Amicas to get out of paying most of those fees.

    But Judge Suzanne Conlon of the U.S. District Court for Northern Illinois is letting Merge escape the lawsuit, ruling that Merge has no legal rights under the contract Amicas inked with Carolina Casualty before the Merge acquisition.

  • Caliper shareholders sue to block $600M PerkinElmer buyout

    Shareholders of Caliper Life Sciences (NSDQ:CALP) are suing to block a $600 million buyout by PerkinElmer Inc. (NYSE:PKI).

    Alleging that the $10.50-per-share bid is inadequate, investors led by plaintiff Betty Greenberg allege that the proposed deal doesn’t account for the 121 percent spike in CALP’s share price over the last year, according to Bloomberg.

    The deal also blocks other potential suitors from upping the ante, according to the lawsuit, filed in the Delaware Chancery Court. Read more

  • Saint-Gobain takes it to the Supremes
    Saint-Gobain SA (ETR:OLG) wants the U.S. Supreme Court to review a $45 million judgment against it in a patent infringement case with Siemens AG (NYSE:SI).

    The French industrial conglomerate filed a petition for a writ of certiorari from the Supremes, formally asking the court to review a U.S. Appeals Court for the Federal Circuit decision that it infringed patents owned by Siemens AG. The appeals court ruled that one of Saint-Gobain’s positron emission tomography scanner infringed the German giant’s patent for another PET device.

    Saint Gobain claims the lower court erred in finding infringement based on the doctrine of equivalents and wants the Supreme Court’s nine justices to take up the matter. Read more

RSS From Medical Design & Outsourcing

  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]

Leave a Reply